Fenofibric Acid
Cat.No:IF1220 Solarbio
CAS:42017-89-0
Molecular Formula:C17H15ClO4
Molecular Weight:318.75
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Cell Cycle > Fenofibric AcidCAS:42017-89-0
Molecular Formula:C17H15ClO4
Molecular Weight:318.75
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:≥98%
Appearance:White to off-white Solid
Qty:
Size:
| CAS | 42017-89-0 |
| Name | Fenofibric Acid |
| Molecular Formula | C17H15ClO4 |
| Molecular Weight | 318.75 |
| Solubility | Soluble in DMSO ≥5mg/mL(Need ultrasonic) |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 255-626-9 |
| MDL | MFCD00792461 |
| SMILES | CC(C)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C(O)=O |
| InChIKey | MQOBSOSZFYZQOK-UHFFFAOYSA-N |
| InChI | InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21) |
| PubChem CID | 64929 |
| Target Point | PPAR,COX2 |
| Passage | Cell Cycle;DNA Damage/DNA Repair;Metabolic Enzyme&Protease;Immunology & Inflammation; |
| Background | Fenofibric Acid is a PPAR agonist; also inhibits COX-2 activity. |
| Biological Activity | Fenofibric acid 是 fenofibrate 的活性代谢物,为 PPAR 激动剂,对 PPARα,PPARγ 和 PPARδ 的 EC50 值分别为 22.4 μM,1.47 μM 和 1.06 μM;Fenofibric acid 同时可抑制 COX-2 的活性,IC50 值为 48 nM。[1-4] |
| Data Literature Source | [1]. Dietz M,et al. Comparative molecular profiling of the PPARα/γ activator aleglitazar: PPAR selectivity,activity and interaction with cofactors. ChemMedChem. 2012 Jun;7(6):1101-11. [2]. Prasad GS,et al. Anti-inflammatory activity of anti-hyperlipidemic drug,fenofibrate,and its phase-I metabolite fenofibric acid: in silico,in vitro,and in vivo studies. Inflammopharmacology. 2017 Dec 13. [3]. Neumeier M,et al. Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro. Biochem Biophys Res Commun. 2006 Nov 24;350(3):731-5. Epub 2006 Sep 27. [4]. Miranda S,et al. Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions. J Cell Physiol. 2012 Jun;227(6):2352-62 |
| Unit | Bottle |
| Specification | 250mg 500mg 1g |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download